Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2010
06/17/2010US20100152274 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
06/17/2010US20100152271 Estrogen receptor modulators and uses thereof
06/17/2010US20100152262 Buccal, polar and non-polar spray containing ondansetron
06/17/2010US20100152261 Novel nitrogen-containing heterocyclic compound
06/17/2010US20100152255 Organic Compounds
06/17/2010US20100152254 Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof
06/17/2010US20100152252 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
06/17/2010US20100152249 Compositons and method for treatment of mood and cognitive impairments
06/17/2010US20100152247 medicament for treating schizophrenia comprising cilostazol
06/17/2010US20100152242 Transdermal Electrotransport Delivery Device Including an Antimicrobial Compatible Reservoir Composition
06/17/2010US20100152234 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
06/17/2010US20100152233 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
06/17/2010US20100152232 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
06/17/2010US20100152228 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
06/17/2010US20100152223 Crystal form of cabergoline
06/17/2010US20100152222 Medicinal Compositions Comprising Buprenorphine And Nalmefene
06/17/2010US20100152216 Monocyclic anilide spirolactam cgrp receptor antagonists
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152210 Purinyl derivatives and their use as potassium channel modulators
06/17/2010US20100152209 Compounds for Modulating TRPV3 Function
06/17/2010US20100152203 Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonists
06/17/2010US20100152197 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
06/17/2010US20100152196 Novel Fused Pyrrolocarbazoles
06/17/2010US20100152193 Pyridazinones
06/17/2010US20100152192 Fused imidazole carboxamides as trpv3 modulators
06/17/2010US20100152191 Cyclopropyl pyrrolidine orexin receptor antagonists
06/17/2010US20100152180 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
06/17/2010US20100152179 Treatment of central nervous system disorders
06/17/2010US20100152178 Imidazole derivatives
06/17/2010US20100152177 Compounds having 5-ht6 receptor affinity
06/17/2010US20100152176 Modulators of Muscarinic Receptors
06/17/2010US20100152175 Pyridine Derivatives and Their Use in The Treatment of Psychotic Disorders
06/17/2010US20100152171 CGRP Antagonists
06/17/2010US20100152168 Substituted benzimidazolone derivatives, medicaments comprising them and their use
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152164 Method For Stabilizing Anti-Dementia Drug
06/17/2010US20100152163 Azepino[4,5-b]indoles and methods of use
06/17/2010US20100152162 Therapeutic and/or preventive agents for a sleep disorder
06/17/2010US20100152158 Substituted Disulfonamide Compounds
06/17/2010US20100152157 6-CYCLOAMINO-3-(PYRIDAZIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE AND DERIVATIVES THEREOF PREPARATION AND THERAPEUTIC APPLICATION THEREOF
06/17/2010US20100152156 2-Azetidinone Derivatives For The Treatment Of Hyperlipidaemic Diseases
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010US20100152152 Therapeutic Use of Nefopam
06/17/2010US20100152150 The application of marine steroid in preparing the medicine of treating neurons damaging
06/17/2010US20100152141 Combinations comprising 5ht6 modulators and cholinesterase inhibitors
06/17/2010US20100152138 Cyclic amine bace-1 inhibitors having a benzamide substituent
06/17/2010US20100152125 Compositions And Methods For The Diagnosis, Treatment, And Prevention Of Amyotrophic Lateral Sclerosis And Related Neurological Diseases
06/17/2010US20100152123 Methods and compositions for treating disorders caused by a deficiency in a gene product of a cln gene
06/17/2010US20100152117 Aequorin-Containing Compositions and Methods of Using Same
06/17/2010US20100152113 Metal-binding therapeutic peptides
06/17/2010US20100152112 Quinoline derivatives as p13 kinase inhibitors
06/17/2010US20100152108 Methods and combination therapies for treating alzheimer's disease
06/17/2010US20100152099 Macrocyclic compounds for inhibition of tumor necrosis factor alpha
06/17/2010US20100151066 Composition for suppressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect
06/17/2010US20100151064 Thiazolhydrazides for treatment of neurodegenerative diseases
06/17/2010US20100151059 Use of vitex agnus castus extracts for preparing a medicament
06/17/2010US20100151034 Granular pharmaceutical composition of atorvastatin for oral administration
06/17/2010US20100151028 Crush resistant delayed-release dosage forms
06/17/2010US20100151027 Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
06/17/2010US20100151023 Time delayed release mechanism for energizing composition and method of use
06/17/2010US20100151021 Compositions Comprising Melperone
06/17/2010US20100151020 Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate
06/17/2010US20100151018 Sustained-release levetiracetam composition and preparation process
06/17/2010US20100151016 Method for producing pharmaceutical tablet
06/17/2010US20100151015 Compositions Comprising Melperone and Controlled-Release Dosage Forms
06/17/2010US20100151014 Pharmaceutical composition
06/17/2010US20100151012 Stabilised pharmaceutical composition containing pregabaline
06/17/2010US20100150995 Process for the production of high-purity 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone
06/17/2010US20100150990 Treatment of inflammation and/or endotoxic shock
06/17/2010US20100150944 Methods and compositions for diagnosis and treatment of depression and anxiety
06/17/2010US20100150933 Cytokine antagonists for neurological and neuropsychiatric disorders
06/17/2010US20100150916 huTNFR1 Selective Antagonists
06/17/2010US20100150906 Antibodies
06/17/2010US20100150899 Pyrazolinone scavengers of free radical
06/17/2010US20100150895 Nutraceutical agent for attenuating the Neurodegenerative process associated with Parkinson's disease
06/17/2010US20100150893 Methods of organ regeneration
06/17/2010US20100150891 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous activity
06/17/2010US20100150882 Hucbc treatment of amyloid associated disease
06/17/2010US20100150875 Indefinite culture of human adult glia without immortalization and therapeutic uses thereof
06/17/2010US20100150866 Hepatitis C Virus Inhibitors
06/17/2010US20100150839 Compositions and Methods for Modulating Cognitive Function
06/17/2010US20100150833 Compounds and amyloid probes thereof for therapeutic and imaging uses
06/17/2010CA2748691A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010CA2747232A1 Compounds for use in the treatment of pain
06/17/2010CA2746701A1 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010CA2746433A1 Benzothiazole amides for detection of amyloid beta
06/17/2010CA2746429A1 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010CA2746428A1 Synthesis of morphine-6-glucuronide or one of the derivatives thereof
06/17/2010CA2746273A1 Small molecule immunomodulators for alzheimer's disease
06/17/2010CA2746251A1 Composition comprising isoflavones
06/17/2010CA2745203A1 3,6-disubstituted xanthylium salts
06/17/2010CA2745052A1 Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines
06/17/2010CA2744498A1 Mlk inhibitors and methods of use
06/16/2010EP2196475A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION
06/16/2010EP2196218A2 Use of anti-TNFalpha antibodies and another drug
06/16/2010EP2196212A1 Preparation and method of administering vaccine and iontophoresis device using the preparation
06/16/2010EP2196203A2 Use of amino-acid based compositions for the treatment of sarcopenia
06/16/2010EP2196200A1 Cyclohexenone derivative for treating or preventing hypesthesia or hyperesthesia caused by diabetes
06/16/2010EP2196199A1 Treatment of phantom phenomena
06/16/2010EP2195318A2 Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes
1 ... 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 ... 1833